Gary M Wheeler, DMD | |
525 Highway 70, Suite A-7, Lakewood, NJ 08701-5847 | |
(732) 367-5900 | |
(732) 367-0502 |
Full Name | Gary M Wheeler |
---|---|
Gender | Male |
Speciality | Dentist - General Practice |
Location | 525 Highway 70, Lakewood, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134234339 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | DI17041 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Gary M Wheeler, DMD 525 Route 70 West, Suite A-7, Lakewood, NJ 08701 Ph: (732) 367-5900 | Gary M Wheeler, DMD 525 Highway 70, Suite A-7, Lakewood, NJ 08701-5847 Ph: (732) 367-5900 |
News Archive
A new poll by WorldPublicOpinion.org (WPO) finds that over the last year, as the health care debate has intensified, a bipartisan consensus that the government is responsible for ensuring access to health care has fractured.
Novavax, Inc. has announced that is has signed a non-exclusive, worldwide license agreement with Wyeth, to obtain rights to a patent application covering virus-like particle (VLP) technology for use in human vaccines in certain fields of use.
GlaxoSmithKline announced today that the U.S. Centers for Disease Control (CDC) Advisory Committee on Immunization Practices (ACIP) voted for a Category B recommendation for meningococcal group B vaccination, including BEXSERO (Meningococcal Group B Vaccine), in individuals aged 16 to 23 (with a preferred age of 16-18).
Intellivest Securities Research, Inc., ("ISR") a Georgia registered investment advisor, has published a Report on BioClinica, Inc. ( BIOC) which serves companies in the pharmaceutical, biotechnology and medical device industries.
Anavex Life Sciences Corp. today announced screening of the first healthy volunteers for the Phase I clinical study of ANAVEX 2-73, its lead compound for the treatment of Alzheimer's disease. ANAVEX 2-73 is the first of a new class of wholly-owned, oral, disease-modifying compounds, which act through sigma-1 receptor agonist as well as muscarinic cholinergic effects and up-regulation of Bcl-2.
› Verified 1 days ago
Dr. Deborah E Brown, DMD Dentist Medicare: Medicare Enrolled Practice Location: 101 2nd St, Lakewood, NJ 08701 Phone: 732-363-6655 | |
Dr. David Plaut Iii, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 321 2nd St, Lakewood, NJ 08701 Phone: 732-901-4404 Fax: 732-364-1555 | |
Matthew Brown, D.M.D Dentist Medicare: Medicare Enrolled Practice Location: 1771 Madison Ave, Lakewood, NJ 08701 Phone: 732-364-2144 Fax: 732-364-3559 | |
Michael Neiman, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 301 Madison Ave, Lakewood, NJ 08701 Phone: 732-363-0177 | |
Brett Wohlstetter, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1328 Route 9, Lakewood, NJ 08701 Phone: 732-363-5558 Fax: 732-363-5512 | |
Dr. Joseph Polinsky, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 301 Madison Ave, Lakewood, NJ 08701 Phone: 732-363-7360 |